Quintiles Transnational Corp. announced it has 300 clinical trials using Electronic Data Capture (EDC). The milestone EDC trial is a Phase II study being conducted for Pacgen Biopharmaceuticals Corporation of Vancouver, British Columbia. Pacgen is studying an anti-infective drug for the treatment of oral candidiasis.

Quintiles began using EDC in 1999 and has seen acceptance of the technology accelerate since then, with more than 94 EDC trials put into production in 2007.

"At Quintiles, EDC is quickly surpassing paper in the collection of clinical trial data as customers are placing increased value on our ability to give them expert guidance in the appropriate use of this technology, as well as the potential for savings in time and cost," said Paula Brown Stafford, Executive Vice President, Global Data Management and Biostatistics, and a member of the CDISC Board of Directors. "We have been able to demonstrate for the pharmaceutical and biotech industries that EDC, when used properly, can make much better use of available resources."

Release date: March 5, 2008
Source: Quintiles